Seneca Biopharma (STU:7NS2) Interest Expense : €-0.01 Mil (TTM As of Dec. 2020)

View and export this data going back to 2013. Start your Free Trial

What is Seneca Biopharma Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Seneca Biopharma's interest expense for the three months ended in Dec. 2020 was € 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2020 was €-0.01 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Seneca Biopharma's Operating Income for the three months ended in Dec. 2020 was € -3.61 Mil. Seneca Biopharma's Interest Expense for the three months ended in Dec. 2020 was € 0.00 Mil. Seneca Biopharma has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Seneca Biopharma Interest Expense Historical Data

The historical data trend for Seneca Biopharma's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seneca Biopharma Interest Expense Chart

Seneca Biopharma Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Interest Expense

Get a 7-Day Free Trial

-1.08

-0.13

-0.01

Seneca Biopharma Quarterly Data
	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20
Interest Expense	Get a 7-Day Free Trial															-	-	-0.01	-	-

Seneca Biopharma Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.01 Mil.

Seneca Biopharma (STU:7NS2) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Seneca Biopharma's Interest Expense for the three months ended in Dec. 2020 was €0.00 Mil. Its Operating Income for the three months ended in Dec. 2020 was €-3.61 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2020 was €0.00 Mil.

Seneca Biopharma's Interest Coverage for the quarter that ended in Dec. 2020 is calculated as

Seneca Biopharma had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Seneca Biopharma (STU:7NS2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Seneca Biopharma Inc (STU:7NS2) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

20271 Goldenrod Lane, Suite 2024, Germantown, MD, USA, 20876

Website

https://www.senecabio.com

Seneca Biopharma Inc is a clinical-stage biopharmaceutical company developing novel treatments for diseases of high unmet medical need. It is focused on the research and development of nervous system therapies based on proprietary human neural stem cells and small molecule compounds.

Seneca Biopharma (STU:7NS2) Headlines

No Headlines